Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial.
The Lancet Infectious Diseases（2019）
摘要
Janssen Pharmaceuticals.
更多查看译文
关键词
vaccine,immunogenicity,escherichia,estella,extra-intestinal
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要